AirSculpt Technologies (AIRS) Projected to Post Earnings on Friday

AirSculpt Technologies (NASDAQ:AIRS) is expected to be posting its Q4 2025 results before the market opens on Friday, May 1st. Analysts expect AirSculpt Technologies to post earnings of ($0.02) per share and revenue of $37.13 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Thursday, April 2, 2026 at 8:30 AM ET.

AirSculpt Technologies (NASDAQ:AIRS) last issued its quarterly earnings results on Tuesday, March 31st. The company reported $0.02 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.03) by $0.05. AirSculpt Technologies had a negative net margin of 7.68% and a negative return on equity of 5.01%. The business had revenue of $33.44 million during the quarter, compared to analyst estimates of $34.93 million. During the same quarter last year, the business posted ($0.09) earnings per share. AirSculpt Technologies’s revenue for the quarter was down 14.8% compared to the same quarter last year. On average, analysts expect AirSculpt Technologies to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

AirSculpt Technologies Price Performance

AIRS opened at $2.49 on Friday. The company has a fifty day moving average price of $2.40 and a two-hundred day moving average price of $3.93. The company has a debt-to-equity ratio of 0.58, a quick ratio of 0.55 and a current ratio of 0.55. AirSculpt Technologies has a 52 week low of $1.51 and a 52 week high of $12.00. The firm has a market capitalization of $175.67 million, a PE ratio of -13.10 and a beta of 2.22.

Insider Buying and Selling

In other AirSculpt Technologies news, major shareholder Jorey Chernett bought 40,000 shares of the stock in a transaction on Friday, April 17th. The stock was purchased at an average price of $2.54 per share, with a total value of $101,600.00. Following the acquisition, the insider owned 7,053,761 shares of the company’s stock, valued at approximately $17,916,552.94. The trade was a 0.57% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Over the last three months, insiders have acquired 810,150 shares of company stock worth $1,987,624. 76.58% of the stock is currently owned by insiders.

Hedge Funds Weigh In On AirSculpt Technologies

Institutional investors and hedge funds have recently made changes to their positions in the company. Jain Global LLC acquired a new position in shares of AirSculpt Technologies in the 4th quarter valued at $138,000. Squarepoint Ops LLC acquired a new position in shares of AirSculpt Technologies in the 3rd quarter valued at $109,000. Barclays PLC grew its holdings in shares of AirSculpt Technologies by 108.9% in the 4th quarter. Barclays PLC now owns 48,843 shares of the company’s stock valued at $97,000 after buying an additional 25,461 shares during the period. Brevan Howard Capital Management LP acquired a new position in shares of AirSculpt Technologies in the 3rd quarter valued at $83,000. Finally, Intech Investment Management LLC acquired a new position in shares of AirSculpt Technologies in the 3rd quarter valued at $80,000. Institutional investors and hedge funds own 91.54% of the company’s stock.

Wall Street Analyst Weigh In

AIRS has been the subject of a number of analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. Wall Street Zen raised shares of AirSculpt Technologies from a “sell” rating to a “hold” rating in a report on Sunday, April 5th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Reduce” and a consensus target price of $6.00.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.